Other lines of research include the development of a vaccine against COVID-19 and the transfusion of plasma from convalescent people. SARS-CoV-2 has approximately 66 therapeutic target proteins, each of which has multiple ligand-binding sites.
Miongozo mingine ya utafiti inajumuisha ukuzaji wa chanjo ya COVID-19 na kuchukua kinga mwili za mtu aliyepona na kuzipeleka kwa mtu mgonjwa kupitia damu. SARS-CoV-2 ina protini za dawa karibu 66, ambazo kila moja ina maeneo mengi yenye molekuli.